Stories abound of healthy people, including athletes, suddenly dying or suffering severe illness without explanation.
Many who have posted links to the reports on social media have suggested a possible relationship to the experimental COVID-19 vaccines. When four practicing physicians in the greater Toronto area died unexpectedly in the past two weeks, their hospitals made a point of insisting their deaths were not related to the vaccines. A fifth area physician, just 27 years old, died Thursday after collapsing during a triathlon.
Now, a national survey by Zogby Strategies has found 17% of adults who received at least two doses of a COVID-19 vaccine say they were diagnosed with a new condition within weeks to several months after getting the shot. The figure was 15% for those who had received at least one shot.
The respondents also were asked if someone they personally knew had been diagnosed with a new medical condition within the same time frame. Overall, 26% reported yes, while 63% reported no.
Significantly, 34% of those ages 18-29 say they know someone who was diagnosed, as did 30% of those ages 30-49, 21% of those ages 50-64, and 18% of those older than 65.
Among those who were medically diagnosed with a new condition, the top conditions were blood clots (21%), heart attack (19%), liver damage (18%), leg or lung clots (17%), and stroke (15%).
The survey was commissioned by Children’s Health Defense, the organization founded by Robert Kennedy Jr. that says its mission is “to end the childhood health epidemics by working to expose causes, eliminate harmful exposures, hold those responsible accountable, seek justice for those injured, and establish safeguards to prevent future harm.”
The survey of 1,038 adults found 67% received one or more COVID-19 vaccines and 33% were unvaccinated. Among the vaccinated, 6% received one dose, 28% two doses, 21% had three doses and 12% took four or more.
Laura Bono, the executive director of CHD, noted the Centers for Disease Control and Prevention reports more than 232 million Americans ages 18-65 have taken at least one dose of a COVID-19 vaccine.
She said the result is “concerning and needs further study.”
“The mRNA vaccine technology is new and clinical trials naturally have no long-term data. CHD believes this survey points to the need for further study,” she said.
The survey found that 58% said it was a good decision to get the vaccine, 28% were neutral and 14% regretted it.